首页> 美国卫生研究院文献>PLoS Clinical Trials >Integrated micro/messenger RNA regulatory networks in essential thrombocytosis
【2h】

Integrated micro/messenger RNA regulatory networks in essential thrombocytosis

机译:整合式微信使RNA调控网络在必需的血小板增多症中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Essential thrombocytosis (ET) is a chronic myeloproliferative disorder with an unregulated surplus of platelets. Complications of ET include stroke, heart attack, and formation of blood clots. Although platelet-enhancing mutations have been identified in ET cohorts, genetic networks causally implicated in thrombotic risk remain unestablished. In this study, we aim to identify novel ET-related miRNA-mRNA regulatory networks through comparisons of transcriptomes between healthy controls and ET patients. Four network discovery algorithms have been employed, including (a) Pearson correlation network, (b) sparse supervised canonical correlation analysis (sSCCA), (c) sparse partial correlation network analysis (SPACE), and, (d) (sparse) Bayesian network analysis–all through a combined data-driven and knowledge-based analysis. The result predicts a close relationship between an 8-miRNA set (miR-9, miR-490-5p, miR-490-3p, miR-182, miR-34a, miR-196b, miR-34b*, miR-181a-2*) and a 9-mRNA set (CAV2, LAPTM4B, TIMP1, PKIG, WASF1, MMP1, ERVH-4, NME4, HSD17B12). The majority of the identified variables have been linked to hematologic functions by a number of studies. Furthermore, it is observed that the selected mRNAs are highly relevant to ET disease, and provide an initial framework for dissecting both platelet-enhancing and functional consequences of dysregulated platelet production.
机译:原发性血小板增多症(ET)是一种慢性骨髓增生性疾病,血小板失控。 ET的并发症包括中风,心脏病发作和血栓形成。尽管在ET队列中已鉴定出增强血小板的突变,但仍未建立起与血栓形成风险有因果关系的遗传网络。在这项研究中,我们旨在通过比较健康对照组和ET患者之间的转录组来确定与ET相关的新型miRNA-mRNA调控网络。已经采用了四种网络发现算法,包括(a)皮尔逊相关网络,(b)稀疏监督规范相关分析(sSCCA),(c)稀疏部分相关网络分析(SPACE)和(d)(稀疏)贝叶斯网络分析-全部通过数据驱动和基于知识的分析相结合。该结果预测了8-miRNA集(miR-9,miR-490-5p,miR-490-3p,miR-182,miR-34a,miR-196b,miR-34b *,miR-181a- 2 *)和9-mRNA集(CAV2,LAPTM4B,TIMP1,PKIG,WASF1,MMP1,ERVH-4,NME4,HSD17B12)。许多研究已将大多数已确定的变量与血液功能联系起来。此外,观察到所选的mRNA与ET疾病高度相关,并为剖析血小板增强和血小板生成失调的功能后果提供了初步的框架。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号